Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Aanbevelingen over eerste- en tweedelijnsbehandeling van auto-immuunencefalitis
jun 2021 | Epilepsie